Active
Small Business
Overview
- Legal name
- ORASURE TECHNOLOGIES INC
- Registered location
- BETHLEHEM, PA, USA
- Website
- Company website ↗
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- Latest award activity
- Aug 19, 2026
Read company summary
ORASURE TECHNOLOGIES INC is associated with UEI Y79RWFLHWDM6 and CAGE 0PNX6 in public federal records. AcornBids currently links 26 prime awards totaling $33.0M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology); In-Vitro Diagnostic Substance Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325413 (In-Vitro Diagnostic Substance Manufacturing). Its public SAM.gov registration lists BETHLEHEM, PA, USA.
At a glance
Lifetime prime obligations$33.0M
Prime awards26
Awards with future end dates2
Top-agency concentration100.0%
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- ORASURE TECHNOLOGIES INC
- UEI
- Y79RWFLHWDM6
- CAGE
- 0PNX6
- Registered address
- 220 EAST 1ST STREET, BETHLEHEM, PA, 18015, USA
- Registration status
- Active
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- SAM activation
- Feb 26, 2026
- Initial registration
- Feb 28, 2000
- Entity start
- May 5, 2000
- SAM updated
- Feb 26, 2026
- Registration expires
- Feb 24, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 36F79722D005965 VII, INVITRO DIAGNOSTICS, REAGENTS, TEST KITS, & TEST SETS, FSS CONTRACT AWARD | Department of Veterans Affairs | $6.4M | Jan 15, 2022 | Not available |
| 75A50122P00014THE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS. | Department of Health and Human Services | $1.2M | Jun 22, 2022 | Jun 22, 2027 |
| HHSO100201500009CIGF::OT::IGF OBJECTIVE: MODIFY THE HIGHLY PROVEN ORAQUICK TEST PLATFORMTO ENABLE ANTIGEN DETECTION OF EBOLA ZAIRE FOR USE WITH AVARIETY OF SAMPLE TYPES: FINGERSTICK WHOLE BLOOD… | Department of Health and Human Services | $10.6M | Jun 2, 2015 | Aug 31, 2022 |
| SPE2DS21P08768507931540!REFERENCE STANDARD | Department of Defense | $0 | Jan 29, 2021 | Feb 3, 2021 |
| SPE2DS21P25588508547873!CONTROL KIT,HEPATIT | Department of Defense | $0 | Sep 22, 2021 | Oct 22, 2021 |
| SPE2DS21P05278507830400!TEST KIT,ALCOHOL DE | Department of Defense | $0 | Dec 1, 2020 | Dec 31, 2020 |
| SPE2DS21P22198508433053!TEST KIT,ALCOHOL DE | Department of Defense | $0 | Aug 11, 2021 | Aug 16, 2021 |
| SPE2DS21P23758508493578!TEST KIT,ALCOHOL DE | Department of Defense | $0 | Sep 7, 2021 | Sep 13, 2021 |
| SPE2DS18P15788505405135!TEST KIT,HUMAN IMMU | Department of Defense | $0 | Apr 16, 2018 | May 16, 2018 |
| 75A50122C00079THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A SECOND-GENERATION ASSAY FOR THE ORAQUICK EBOLA RAPID ANTIGEN TEST AS A SUSTAINABLE, ENHANCED TEST INCLUDING ALTERNATIVE REAGENTS… | Department of Health and Human Services | $15.5M | Jan 3, 2023 | Jun 30, 2027 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Feb 26, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Feb 28, 2000 |
| Entity start | May 5, 2000 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325413 — In-Vitro Diagnostic Substance Manufacturing | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| LEE ANN SMOLICK | Government business | Contact method not published | SAM registration | Not available |
| LEEANN SMOLICK | Alternate government business | Contact method not published | SAM registration | Not available |
| MARY PALMIERI | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325413 — In-Vitro Diagnostic Substance Manufacturing
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
49 awards
26 awards
25 awards
20 awards
18 awards
16 awards
15 awards
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit